Transforming today’s health care means leveraging new digital technology and capabilities. That means all hands on deck – especially where computerization and speed is concerned; and when you think of those two terms – you have to be thinking of Intel.
Today we have on the show, the Head of Intel’s Head of Global Health and Life Sciences, Jennifer Esposito. She’s going to talk about genomics, Intel’s sector strategy, the personalization of health care, and their newest efforts into combating chronic disease in a world with physician shortage.
It’s all about the power of tomorrow’s technology and health care…right here on Red Hot Healthcare.
This Red Hot Healthcare episode includes:
- Intel’s quad component business strategy per sustaining its growth and wide net in health care
- Successful partnering with, and thoughts on precision medicine, pharmaceutical, and genomic companies
- AI and machine learning in clinical and administrative operations
- Intel’s latest efforts in a health ‘ALL-IN-ONE’ computer, for global health, future physician shortages, and quality of care.
Below is a short transcript snippet for this powerful listen.
[on PRECISION MEDICINE]
DR. STEVE: “I want to go ahead and ask you where you see precision medicine, as a healthcare segment, needing to make more strides. Perhaps in pharma, providers, payers – and maybe even patients and policy.”
ESPOSITO: “I think there’s definitely strides to be made in all of those segments and spaces. Leading healthcare providers already offer some level of precision medicine for specific types of medicine such as oncology – to identify genetic abnormalities of cancer, and map that to targeted therapy.
In pediatrics you already see it, where you have children with extremely rare diseases. Where you can help avoid a diagnostic odyssey that goes on for a long period of time, without a lot of fruitful decisions around the diagnosis itself. These are some of the places we’re seeing [precision medicine]today, and it’s often closely tied with research.
One of the things, I think, that would help providers would be better visualization tools. It’s very hard to expect a community doctor or even an oncologist to become experts in genomics. There’s actually a strong need there to have the right people to have those providers navigate throughout the system; and opportunities for patients to join clinical trials that are targeted for the right drugs.
There’s a lot of things that can be done here. Something like a visualization tool that can take aggregated data and help make sense of it, to help make doctors in all types of hospitals make better decisions.”
[ON GLOBAL HEALTH TECHNOLOGIES]
DR. STEVE: “I know that you’re well aware, as we go out the next 10-15 years, there’s a strong likelihood for a shortage of physicians and population aging, where people live longer.
What technologies do you see Jennifer, as necessary to take on these challenges?”
ESPOSITO: “For a very long time, we’ve been working on things like telemedicine and virtual care. We call this in our ‘model-distributed care’ – so it’s really about taking care outside of the hospital. That care happens either in the home or into the community.
You’re seeing this around the world, where there are shortages of physicians; or there are capacity issues as patients leave their rural environments for the big city hospitals. This can be very difficult to do.
As a result, you’re often not able to deliver the kind of primary care that chronic patients need. We’ve done a lot of work in this space, and one of the things we’ve done is to build a ‘reference design’. This is a concept of a health all-in-one computer – and a capability we’ve been working on.
This brings a PC in the community that can be utilized and run by a community health worker. This is not a physician – but someone in the community that has been trained to capture vital signs and do other -“
DR. STEVE: “That’s great.”
ESPOSITO: “Yeah, we’ve seen this applied and there’s a lot of interest around the world in this product. It’s both in developed and developing markets, and I think this has a lot of potential to help bring some technology to help drive efficiencies in care – in a relatively low cost model.
We’ve focused quite a lot of energy on this. We’ve used a lot of testing and user experience to really hone in on the right design for the device.
DR. STEVE: “Bringing, what I feel like, is necessary humanity to technology. Looking at those global needs out there, and being able to take the value of a human being with a compassionate heart – and putting them behind that technology to make a real difference.
ESPOSITO: “Absolutely. It also brings up the opportunity to train more people in these communities. To give them new business models and opportunities for new jobs.
The other thing that we’ve seen, to some degree, are similar technologies being used to bring intensive unit care capabilities into very rural environments. You might have a hospital bed, but it’s not meant to be used for intensive care.
So if you’ve building out a capability of remote monitoring and telemedicine with specialists in city hospitals, you can centralize the care – and distribute that out to more rural environments.”